Rilmazafone hydrochloride is primarily used in the field of medicine as a non-benzodiazepine hypnotic agent. It is prescribed to treat insomnia and other sleep disorders by promoting sedation and improving sleep quality. The compound is metabolized in the body to produce active metabolites that act on the central nervous system, specifically targeting GABA receptors to induce calming effects. It is often favored for its lower risk of dependency and fewer side effects compared to traditional benzodiazepines. Additionally, it is used in clinical settings to manage anxiety-related conditions, providing a safe and effective option for short-term treatment. Its rapid onset and relatively short half-life make it suitable for patients who struggle with falling asleep but need to avoid prolonged sedation.